GnRH agonists for PMDD: does it work?

Yes, for many women with severe PMDD, especially when other treatments haven't worked. GnRH agonists stop the brain's signal to the ovaries, so ovulation pauses and estrogen and progesterone stop rising and falling each month. Because PMDD is a different reaction to that monthly hormone swing rather than to abnormal hormone levels, taking the swing away often takes the symptoms with it too.

A 2023 clinical guideline on treatment-resistant PMDD describes this as one of the most effective options once SSRIs, hormonal options, and therapy haven't brought enough relief ( [1]). It's not usually a first step: most specialists reserve GnRH agonists for treatment-resistant PMDD, because stopping ovarian hormone production brings its own side effects and needs monitoring over time.

This page focuses on PMDD. If milder premenstrual symptoms fit your situation better, GnRH agonists for PMS: does it work? covers that evidence separately. And if you're still working out whether your pattern fits the PMDD diagnosis, PMDD (premenstrual dysphoric disorder), explained walks through the criteria.

The evidence comes from a mix of an older meta-analysis, a newer systematic review, and small mechanistic trials that explain why the approach works.

The 2004 meta-analysis found GnRH agonists worked somewhat better on physical symptoms like bloating and breast tenderness than on mood symptoms, though that difference wasn't statistically significant ( [2]). The effect on mood is still there, just not as cleanly separated out in the data. For a broader look at how PMS and PMDD evidence holds up across topics, see PMS and PMDD research, summarised.

In the trials behind this evidence, leuprolide (Lupron) was given as a monthly depot injection to suppress the ovaries, with add-back hormones introduced after about three months of suppression ( [4], [5]). Goserelin (Zoladex), given as an implant, has been studied for PMS alongside leuprolide, though there's no published trial specifically on goserelin for PMDD.

Unlike SSRIs, which some women take only in the days before their period, GnRH agonists suppress the whole cycle continuously rather than targeting the luteal phase. That's part of why they're reserved for more severe, treatment-resistant cases.

A typical course, based on how the research and the 2023 guideline describe it, looks like this:

1. Start the GnRH agonist to suppress ovulation, usually as a monthly injection or implant.
2. Expect hormone levels, and often symptoms, to shift over the first one to two months as the ovaries go quiet.
3. Add back low-dose estrogen and progesterone, typically a few months in, to protect against menopause-like side effects and bone loss without bringing symptoms back ( [1], [3]).
4. Keep tracking symptoms and bone health with your prescribing doctor for as long as treatment continues.

Exact timing and doses are a decision for the prescribing doctor, since add-back needs to be tuned to each person.

GnRH agonists put the body into a temporary, medically induced menopause, so the side effects mostly look like menopause symptoms:

• Hot flashes and night sweats
• Vaginal dryness
• Headaches
• Mood changes in the early weeks, before add-back hormones are introduced
• Bone density loss with long-term use, which is the main reason doctors add back estrogen and progesterone ( [3])

Add-back therapy, a low, steady dose of estrogen and progesterone alongside the GnRH agonist, is designed to soften these effects. The 2004 meta-analysis found add-back didn't reduce how well the treatment worked ( [2]). You don't have to trade symptom relief for bone protection.

Because this is a longer-term hormonal treatment, most guidelines recommend regular monitoring, including bone density scans if treatment continues for more than a year or so.

GnRH agonists aren't usually a first or even second option. The 2023 treatment-resistant PMDD guideline positions them after SSRIs, certain hormonal contraceptives, and cognitive behavioral therapy haven't given enough relief ( [1]). PMDD treatment: what actually helps walks through those earlier steps.

They're generally avoided, or used with extra caution, if you:

• Are pregnant or trying to become pregnant
• Have osteoporosis or another condition that already weakens bone
• Haven't yet tried first-line PMDD treatments
• Don't have access to a doctor who can manage add-back hormones and monitor bone health over time

Finding that doctor matters. GnRH agonists for PMDD work best with someone who understands both the diagnosis and the add-back protocol, which not every gynecologist or psychiatrist has used. Finding a PMDD specialist has pointers on that search.

GnRH agonists treat the hormonal trigger, not everything that makes the week before your period harder. Most people pair it with:

• Cognitive behavioral therapy, to build on the mood stability the medication provides
• A symptom diary or chart, so you and your doctor can see what's changing and when
• Support for the relationships affected during the days before your period, since a cycle pattern doesn't make an argument or a hurt feeling imaginary

Niyora is a PMS and PMDD support app. If you want somewhere to put a fight before you answer, Niyora's Moon lets you write what happened, see it from another angle, and draft a reply you can hold for 20 minutes.

It also gives you an estimated PMS window, useful for noticing whether a low day lines up with your cycle while you and your doctor work out whether GnRH agonists make sense for you.

None of this replaces the medication's effect on hormones. It just covers the parts of the month a prescription doesn't reach.

GnRH agonists take weeks to change your hormones, and longer to get the add-back dose right. In the meantime, here's what to do with a hard moment tonight:

1. Leave the room before you say something you can't take back. Tell the other person you need 20 minutes and that you'll come back.
2. Breathe out for six counts, longer than the breath in. That slows your heart rate faster than a deep breath alone.
3. Write down what happened while it's fresh, even a few lines. It's easier to sort out what's the moment and what's the real issue later, with notes in front of you.
4. If the thought behind the feeling is "I can't do this anymore" in a way that scares you, treat that as reason to call a GP or go to urgent care, not something to wait out alone.

None of this fixes the hormone pattern underneath. It just gets you through tonight while you and a doctor figure out whether GnRH agonists, or another option, are the right next step.